Alerts Sign-up
Federal Express Corporation, commonly known as FedEx, has announced the expansion of its state-of-the-art life sciences center in Gimpo City, Gyeonggi Province. This move is part of a strategic effort to meet the increasing demand for specialized healthcare delivery solutions and support the growth of the life sciences industry both domestically and internationally.
The newly expanded Gimpo Life Sciences Center now covers an area of 2,288 square meters, approximately three times larger than its previous size. It features five temperature-controlled zones ranging from minus 150 degrees Celsius to 25 degrees Celsius, all monitored around the clock to comply with cold chain standards required by the pharmaceutical industry. The facility has received KGSP certification and includes temperature control functions to meet both domestic and international logistics needs.
FedEx aims to enhance its logistics expertise in the life sciences sector through this expansion. The company plans to ensure rapid and stable transportation of key healthcare logistics such as investigational medicinal products (IMP), biological samples, and pharmaceutical products. This will allow pharmaceutical and clinical trial companies to focus more on patient care.
